Literature DB >> 30799850

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo.

Na Jia1, Haoan Wu2, Juanli Duan1, Chunxue Wei1, Kaixuan Wang2, Yu Zhang3, Xiaohua Mao4.   

Abstract

Because of their critical role in regulating immune responses, macrophages have continuously been the subject of intensive research and represent a promising therapeutic target in many disorders, such as autoimmune diseases, atherosclerosis, and cancer. RNAi-mediated gene silencing is a valuable approach of choice to probe and manipulate macrophage function; however, the transfection of macrophages with siRNA is often considered to be technically challenging, and, at present, few methodologies dedicated to the siRNA transfer to macrophages are available. Here, we present a protocol of using polyethyleneimine-coated superparamagnetic iron oxide nanoparticles (PEI-SPIONs) as a vehicle for the targeted delivery of siRNA to macrophages. PEI-SPIONs are capable of binding and completely condensing siRNA when the Fe:siRNA weight ratio reaches 4 and above. In vitro, these nanoparticles can efficiently deliver siRNA into primary macrophages, as well as into the macrophage-like RAW 264.7 cell line, without compromising cell viability at the optimal dose for transfection, and, ultimately, they induce siRNA-mediated target gene silencing. Apart from being used for in vitro siRNA transfection, PEI-SPIONs are also a promising tool for delivering siRNA to macrophages in vivo. In view of its combined features of magnetic property and gene-silencing ability, systemically administered PEI-SPION/siRNA particles are expected not only to modulate macrophage function but also to enable macrophages to be imaged and tracked. In essence, PEI-SPIONs represent a simple, safe, and effective nonviral platform for siRNA delivery to macrophages both in vitro and in vivo.

Entities:  

Year:  2019        PMID: 30799850     DOI: 10.3791/58660

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  5 in total

Review 1.  Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses.

Authors:  Clément Anfray; Aldo Ummarino; Fernando Torres Andón; Paola Allavena
Journal:  Cells       Date:  2019-12-23       Impact factor: 6.600

2.  Activatable "Matryoshka" nanosystem delivery NgBR siRNA and control drug release for stepwise therapy and evaluate drug resistance cancer.

Authors:  Xinzhi Xu; Chunxiang Jin; Kai Zhang; Yang Cao; Junjun Liu; Yue Zhang; Haitao Ran; Ying Jin
Journal:  Mater Today Bio       Date:  2022-03-19

3.  Biodistribution, biocompatibility and targeted accumulation of magnetic nanoporous silica nanoparticles as drug carrier in orthopedics.

Authors:  Hilke Catherina Janßen; Nina Angrisani; Stefan Kalies; Florian Hansmann; Manfred Kietzmann; Dawid Peter Warwas; Peter Behrens; Janin Reifenrath
Journal:  J Nanobiotechnology       Date:  2020-01-15       Impact factor: 10.435

Review 4.  Exploiting Manipulated Small Extracellular Vesicles to Subvert Immunosuppression at the Tumor Microenvironment through Mannose Receptor/CD206 Targeting.

Authors:  Maria Luisa Fiani; Valeria Barreca; Massimo Sargiacomo; Flavia Ferrantelli; Francesco Manfredi; Maurizio Federico
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

5.  Gold Nanoparticles Modified With Polyethyleneimine Disturbed the Activity of Drug-Metabolic Enzymes and Induced Inflammation-Mediated Liver Injury in Mice.

Authors:  Hanqing Chen; Shuang Zhou; Meilin Zhu; Bing Wang; Wei Chen; Lingna Zheng; Meng Wang; Weiyue Feng
Journal:  Front Pharmacol       Date:  2021-07-15       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.